Serina Therapeutics, Inc.
AGE
Revenue
51.00k
▲46.00k▲920.00%
3 Months ChangeAssets
10.71M
▼-148.00k▼-1.36%
3 Months ChangeLiabilities
27.10M
▲11.94M▲78.71%
3 Months ChangeFree Cash Flow
-1.59M
▲477.00k▲23.07%
48 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-06-10
Form 8-K
ID: 0001493152-24-023333
2024-05-14
Form 8-K
ID: 0001493152-24-019262
2024-05-14
Form 10-Q
ID: 0001493152-24-019248
2024-05-03
Form 8-K
ID: 0001493152-24-017731
2024-04-17
Form 8-K
ID: 0001493152-24-015037
2024-04-01
Form 8-K
ID: 0001493152-24-012530
2024-03-22
Form 8-K
ID: 0001493152-24-011024
2024-03-14
Form 8-K
ID: 0001493152-24-009959
2024-03-07
Form 8-K
ID: 0001493152-24-009224
2024-02-14
Form 8-K
ID: 0001493152-24-006677